Phillip F. Pierce
- Microbiology top 1%
- Microbial infections and disease research 5
- Bacterial Infections and Vaccines 4
- Virology top 5%
- HIV Research and Treatment 7
- Molecular Medicine top 5%
- Infectious Diseases top 5%
-
- Pneumonia and Respiratory Infections 11
- Pneumocystis jirovecii pneumonia detection and treatment 5
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Drug-Induced Adverse Reactions 3
-
- Blood groups and transfusion 4
- Co-authors
- Dennis M. GraselaJulie PassarellHoward MayerThaddeus H. GraselaPaul G. AmbroseHitoshi KotaniJ W ShihShyh‐Ching Lo
- Partner nations
- United StatesCanadaCosta Rica
In The Last Decade
Phillip F. Pierce
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Microbiology 384
- Virology 187
- Molecular Medicine 147
- Infectious Diseases 452
- Applied Microbiology and Biotechnology 47
Countries citing papers authored by Phillip F. Pierce
This map shows the geographic impact of Phillip F. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip F. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip F. Pierce more than expected).
Fields of papers citing papers by Phillip F. Pierce
This network shows the impact of papers produced by Phillip F. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip F. Pierce. The network helps show where Phillip F. Pierce may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Phillip F. Pierce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2005 | 19 | |
| 3 | 2005 | 22 | |
| 4 | 2003 | 35 | |
| 5 | 2002 | 32 | |
| 6 | 2001 | 237 | |
| 7 | 2001 | 14 | |
| 8 | 1996 | 7 | |
| 9 | 1996 | 26 | |
| 10 | 1995 | 2 | |
| 11 | 1994 | 32 | |
| 12 | 1994 | 55 | |
| 13 | 1993 | 13 | |
| 14 | 1993 | 76 | |
| 15 | 1993 | 3 | |
| 16 | 1992 | 3 | |
| 17 | 1992 | 94 | |
| 18 | 1992 | 86 | |
| 19 | 1991 | 86 | |
| 20 | 1989 | 10 |
About Phillip F. Pierce
Phillip F. Pierce is a scholar working on Virology, Microbiology and Otorhinolaryngology, having authored 42 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (11 papers), HIV Research and Treatment (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Microbial infections and disease research (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Bacterial Infections and Vaccines (4 papers), Blood groups and transfusion (4 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Microbiology (384 citations), Virology (187 citations) and Molecular Medicine (147 citations). Phillip F. Pierce has collaborated with scholars based in United States, Canada and Costa Rica. Frequent co-authors include Dennis M. Grasela, Julie Passarell, Howard Mayer, Thaddeus H. Grasela, Paul G. Ambrose, Hitoshi Kotani, J W Shih, Shyh‐Ching Lo, Douglas J. Wear and J W Shih. Their work appears in journals such as The Lancet, JAMA and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.